# A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

> **NCT00854659** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ABT-102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00854659
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-06
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854659, "A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00854659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*